160 related articles for article (PubMed ID: 36117441)
21. Risk assessment model for heart failure in Chinese patients with Takayasu's arteritis.
Wang YJ; Ma LL; Liu Y; Yan Y; Sun Y; Wang YS; Dai XM; Ji ZF; Ma LY; Chen HY; Jiang LD
Clin Rheumatol; 2021 Oct; 40(10):4117-4126. PubMed ID: 34021842
[TBL] [Abstract][Full Text] [Related]
22. The effects of biological agents on vascular structural lesions in Takayasu's arteritis.
Erbasan F; Uçar İ; Aslan B; Yazisiz V; Terzioğlu ME
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):135-141. PubMed ID: 33506752
[TBL] [Abstract][Full Text] [Related]
23. Cardiopulmonary involvement in Takayasu's arteritis.
Brennan DN; Warrington KJ; Crowson CS; Schmidt J; Koster MJ
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):46-50. PubMed ID: 28628465
[TBL] [Abstract][Full Text] [Related]
24. Mortality and cardiovascular morbidity among patients diagnosed with Takayasu's arteritis: a Danish nationwide cohort study.
Egebjerg K; Baslund B; Obel N; Faurschou M
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):91-94. PubMed ID: 32359036
[TBL] [Abstract][Full Text] [Related]
25. Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: A systematic review and meta-analysis.
Barra L; Yang G; Pagnoux C;
Autoimmun Rev; 2018 Jul; 17(7):683-693. PubMed ID: 29729444
[TBL] [Abstract][Full Text] [Related]
26. Development of a colour Doppler ultrasound scoring system in patients of Takayasu's arteritis and its correlation with clinical activity score (ITAS 2010).
Sinha D; Mondal S; Nag A; Ghosh A
Rheumatology (Oxford); 2013 Dec; 52(12):2196-202. PubMed ID: 24014648
[TBL] [Abstract][Full Text] [Related]
27. The feasibility of quantitative assessment of dynamic
Duan Y; Zan K; Zhao M; Ng YL; Li H; Ge M; Chai L; Cui X; Quan W; Li K; Zhou Y; Chen L; Wang X; Cheng Z
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):81-92. PubMed ID: 37691022
[TBL] [Abstract][Full Text] [Related]
28. Microscopic colitis in patients with Takayasu's arteritis: a potential association between the two disease entities.
Kanıtez NA; Toz B; Güllüoğlu M; Erer B; Esen BA; Omma A; Şahinkaya Y; İliaz R; Çavuş B; Gül A; İnanç M; Karaca Ç; Kamalı S
Clin Rheumatol; 2016 Oct; 35(10):2495-9. PubMed ID: 26742755
[TBL] [Abstract][Full Text] [Related]
29. [The clinical characteristics of Takayasu's arteritis with glomerulonephropathy].
Chen Z; Yang YJ; Li J; Tian XP
Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):129-133. PubMed ID: 29397599
[No Abstract] [Full Text] [Related]
30. IL-9-producing Th9 cells may participate in pathogenesis of Takayasu's arteritis.
Pan LL; Du J; Gao N; Liao H; Wan J; Ci WP; Yang C; Wang T
Clin Rheumatol; 2016 Dec; 35(12):3031-3036. PubMed ID: 27629397
[TBL] [Abstract][Full Text] [Related]
31. Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
Sun Y; Ma L; Chen H; Kong X; Lv P; Dai X; Ji Z; Yang C; Dai S; Wu L; Zou Y; Lin J; Shi H; Yu Q; Jiang L
Clin Rheumatol; 2018 Oct; 37(10):2789-2795. PubMed ID: 29687289
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of Older Patients with Takayasu's Arteritis: A Two-Center, Cross-Sectional, Retrospective Cohort Study.
Oliveira JCS; Santos AMD; Aguiar MF; Gonçalves Junior J; Souza AWS; Pereira RMR; Shinjo SK
Arq Bras Cardiol; 2023; 120(1):e20220463. PubMed ID: 36629607
[TBL] [Abstract][Full Text] [Related]
33. The role of CD8
Li T; Gao N; Cui W; Zhao L; Du J; Shi X; Zhu J; Qiao Z; Guo S; Pan L
Clin Rheumatol; 2022 Jan; 41(1):167-176. PubMed ID: 34494213
[TBL] [Abstract][Full Text] [Related]
34. Using the co-expression network of T cell-activation-related genes to assess the disease activity in Takayasu's arteritis patients.
Tian Y; Li J; Tian X; Zeng X
Arthritis Res Ther; 2021 Dec; 23(1):303. PubMed ID: 34915894
[TBL] [Abstract][Full Text] [Related]
35. Impact of coronary involvement on long-term outcomes in patients with Takayasu's arteritis.
Wang H; Liu Z; Shen Z; Fang L; Zhang S
Clin Exp Rheumatol; 2020; 38(6):1118-1126. PubMed ID: 32083549
[TBL] [Abstract][Full Text] [Related]
36. HADS-depression score is a mediator for illness perception and daily life impairment in Takayasu's arteritis.
Erdal S; Nalbantoğlu B; Gür MB; Yıldırım M; Kılıçarslan A; Kaymaz-Tahra S; Alibaz-Öner F; Yay M; Mumcu G; Direskeneli H
Clin Rheumatol; 2021 Oct; 40(10):4109-4116. PubMed ID: 33839991
[TBL] [Abstract][Full Text] [Related]
37. Comparison of long-term survival after endovascular treatment versus medical therapy in patients with Takayasu's arteritis and pulmonary artery stenosis.
Huang Z; Dong F; Wang M; Hu F; Liu X
Clin Exp Rheumatol; 2023 Apr; 41(4):887-892. PubMed ID: 36700639
[TBL] [Abstract][Full Text] [Related]
38. Clinical study of carotid superb microvascular imaging in evaluating the activity of Takayasu's arteritis.
Liu FJ; Ci WP; Cheng Y
Front Cardiovasc Med; 2023; 10():1051862. PubMed ID: 36950292
[TBL] [Abstract][Full Text] [Related]
39. [Fundus manifestation and treatment of Takayasu's arteritis].
Wang WW; Ye JJ; Chen YX; Dai RP
Zhonghua Yan Ke Za Zhi; 2012 Feb; 48(2):124-30. PubMed ID: 22490947
[TBL] [Abstract][Full Text] [Related]
40. An increased major vessel uptake by 18F-FDG-PET/CT in NIH criteria inactive patients with Takayasu's arteritis.
Han Q; Liang Q; Kang F; Wang J; Wu Z; Zhu P
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):88-92. PubMed ID: 29465347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
